New Scientific Publication Supports Agilvax’s Novel Immunotherapy … – Business Wire (press release)
|
New Scientific Publication Supports Agilvax's Novel Immunotherapy …
Business Wire (press release) Agilvax has published preclinical data regarding its immunotherapy candidate, AX09, for metastatic breast cancer in the journal OncoImmunology. |
